| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.081 | 0.06 |
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | 0.32 | 0.06 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.076 | 0.06 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.073 | 0.06 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.06 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.11 | 0.06 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.06 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.076 | 0.06 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | 0.07 | 0.06 |
| mRNA | Roscovitine | FIMM | pan-cancer | AAC | -0.31 | 0.06 |